Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-04-24

Clinical Trial Update: Platelet Rich Plasma for Frontal Fibrosing Alopecia [NA]

View source ↗

Summary

A University of Minnesota-sponsored trial evaluating platelet-rich plasma for frontal fibrosing alopecia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Platelet-Rich Plasma (PRP) Therapy (platelet-rich plasma)

Snippet

Sponsor: University of Minnesota | Conditions: Frontal Fibrosing Alopecia | NA | Status: WITHDRAWN